Viral respiratory tract infections and asthma in early life: Cause and effect?

Clinical and Experimental Allergy

Volumn 44, Issue 1, 2014, Pages 9-19

  Mackenzie, K J ^a   Anderton, S M ^a,b   Schwarze, J ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; INTERLEUKIN 25; INTERLEUKIN 33; MESSENGER RNA; THYMIC STROMAL LYMPHOPOIETIN;

ANTIGEN PRESENTING CELL; ASTHMA; DENDRITIC CELL; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EPITHELIUM CELL; HUMAN; IMMUNITY; LUNG; LYMPHOID CELL; MODULATION; PRIORITY JOURNAL; REVIEW; SENSITIZATION; T LYMPHOCYTE; VIRAL RESPIRATORY TRACT INFECTION;

AGE FACTORS; ASTHMA; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; HUMANS; INFANT; INFANT, NEWBORN; LUNG; RESPIRATORY TRACT INFECTIONS; RISK;

EID: 84890808510     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12139     Document Type: Review

References (102)

1. Asthma UK. 2013. Asthma facts and FAQs and triggers A-Z. Available at: http://www.asthma.org.uk/asthma-facts-and-statistics and http://www.asthma.org.uk/knowledge-triggers-a-z. (Accessed 17th May 2013).
2. Papadopoulos NG, Christodoulou I, Rohde G et al. Viruses and bacteria in acute asthma exacerbations - A GA2LEN-DARE* systematic review. Allergy 2011; 66:458-68.
3. Busse WW, Lemanske RF Jr, Gern JE. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 2010; 376:826-34.
4. Simpson CR, Sheikh A. Trends in the epidemiology of asthma in England: a national study of 333, 294 patients. J R Soc Med 2010; 103:98-106.
5. Gupta R, Sheikh A, Strachan DP, Anderson HR. Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy 2004; 34:520-6.
6. Kim HY, DeKruyff RH, Umetsu DT. The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat Immunol 2010; 11:577-84.
7. Spycher BD, Silverman M, Kuehni CE. Phenotypes of childhood asthma: are they real? Clin Exp Allergy 2010; 40:1130-41.
8. Olenec JP, Kim WK, Lee WM et al. Weekly monitoring of children with asthma for infections and illness during common cold seasons. J Allergy Clin Immunol 2010; 125:1001-6, e1.
9. Johnston NW, Johnston SL, Duncan JM et al. The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol 2005; 115:132-8.
10. Bizzintino J, Lee WM, Laing IA et al. Association between human rhinovirus C and severity of acute asthma in children. Eur Respir J 2011; 37:1037-42.
11. Johnston SL, Pattemore PK, Sanderson G et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995; 310:1225-9.
12. Jartti T, Lee WM, Pappas T, Evans M, Lemanske RF Jr, Gern JE. Serial viral infections in infants with recurrent respiratory illnesses. Eur Respir J 2008; 32:314-20.
13. Murray CS, Poletti G, Kebadze T et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 2006; 61:376-82.
14. Green RM, Custovic A, Sanderson G, Hunter J, Johnston SL, Woodcock A. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ 2002; 324:763.
15. Warner JO. The early life origins of asthma and related allergic disorders. Arch Dis Child 2004; 89:97-102.
16. Holt PG, Sly PD. Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat Med 2012; 18:726-35.
17. Sigurs N, Aljassim F, Kjellman B et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 2010; 65:1045-52.
18. Sigurs N, Gustafsson PM, Bjarnason R et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005; 171:137-41.
19. Schauer U, Hoffjan S, Bittscheidt J et al. RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life. Eur Respir J 2002; 20:1277-83.
20. Henderson J, Hilliard TN, Sherriff A, Stalker D, Al Shammari N, Thomas HM. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study. Pediatr Allergy Immunol 2005; 16:386-92.
21. Wu P, Dupont WD, Griffin MR et al. Evidence of a causal role of winter virus infection during infancy in early childhood asthma. Am J Respir Crit Care Med 2008; 178:1123-9.
22. Thomsen SF, van der Sluis S, Stensballe LG et al. Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. Am J Respir Crit Care Med 2009; 179:1091-7.
23. Oddy WH, de Klerk NH, Sly PD, Holt PG. The effects of respiratory infections, atopy, and breastfeeding on childhood asthma. Eur Respir J 2002; 19:899-905.
24. Lemanske RF Jr, Jackson DJ, Gangnon RE et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol 2005; 116:571-7.
25. Jackson DJ, Gangnon RE, Evans MD et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008; 178:667-72.
26. Jackson DJ, Evans MD, Gangnon RE et al. Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med 2012; 185:281-5.
27. Kusel MM, de Klerk NH, Kebadze T et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007; 119:1105-10.
28. Larche M, Robinson DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 2003; 111:450-63.
29. Schneider D, Hong JY, Popova AP et al. Neonatal rhinovirus infection induces mucous metaplasia and airways hyperresponsiveness. J Immunol 2012; 188:2894-904.
30. Siegle JS, Hansbro N, Herbert C et al. Early-life viral infection and allergen exposure interact to induce an asthmatic phenotype in mice. Respir Res 2010; 11:14.
31. Al-Garawi A, Fattouh R, Botelho F et al. Influenza A facilitates sensitization to house dust mite in infant mice leading to an asthma phenotype in adulthood. Mucosal Immunol 2012; 4:682-94.
32. Ripple MJ, You D, Honnegowda S et al. Immunomodulation with IL-4R alpha antisense oligonucleotide prevents respiratory syncytial virus-mediated pulmonary disease. J Immunol 2010; 185:4804-11.
33. O'Donnell DR, Openshaw PJ. Anaphylactic sensitization to aeroantigen during respiratory virus infection. Clin Exp Allergy 1998; 28:1501-8.
34. Schwarze J, Hamelmann E, Bradley KL, Takeda K, Gelfand EW. Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. J Clin Invest 1997; 100:226-33.
35. Torres D, Dieudonne A, Ryffel B et al. Double-stranded RNA exacerbates pulmonary allergic reaction through TLR3: implication of airway epithelium and dendritic cells. J Immunol 2010; 185:451-9.
36. Wang H, Su Z, Schwarze J. Healthy but not RSV-infected lung epithelial cells profoundly inhibit T cell activation. Thorax 2009; 64:283-90.
37. van Rijt LS, Jung S, KleinJan A et al. In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma. J Exp Med 2005; 201:981-91.
38. Hammad H, Lambrecht BN. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol 2008; 8:193-204.
39. Mayer AK, Bartz H, Fey F, Schmidt LM, Dalpke AH. Airway epithelial cells modify immune responses by inducing an anti-inflammatory microenvironment. Eur J Immunol 2008; 38:1689-99.
40. Zhou B, Comeau MR, Smedt TD et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol 2005; 6:1047-53.
41. Qiao J, Li A, Jin X. TSLP from RSV-stimulated rat airway epithelial cells activates myeloid dendritic cells. Immunol Cell Biol 2011; 89:231-8.
42. Xu G, Zhang L, Wang DY et al. Opposing roles of IL-17A and IL-25 in the regulation of TSLP production in human nasal epithelial cells. Allergy 2009; 65:581-9.
43. Soumelis V, Reche PA, Kanzler H et al. Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP. Nat Immunol 2002; 3:673-80.
44. Rochman I, Watanabe N, Arima K, Liu Y-J, Leonard WJ. Cutting edge: direct action of thymic stromal lymphopoietin on activated human CD4+ T cells. J Immunol 2007; 178:6720-4.
45. Wang YH, Angkasekwinai P, Lu N et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 2007; 204:1837-47.
46. Le Goffic R, Arshad MI, Rauch M et al. Infection with Influenza Virus induces IL-33 in murine lungs. Am J Respir Cell Mol Biol 2011; 45:1125-32.
47. Komai-Koma M, Xu D, Li Y, McKenzie ANJ, McInnes IB, Liew FY. IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol 2007; 37:2779-86.
48. Zhiguang X, Wei C, Steven R et al. Over-expression of IL-33 leads to spontaneous pulmonary inflammation in mIL-33 transgenic mice. Immunol Lett 2010; 131:159-65.
49. Chang Y-J, Kim HY, Albacker LA et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 2011; 12:631-8.
50. Barlow JL, McKenzie ANJ. Nuocytes: expanding the innate cell repertoire in type-2 immunity. J Leuko Biol 2011; 90:867-74.
51. Spits H, Artis D, Colonna M et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol 2013; 13:145-9.
52. Monticelli LA, Sonnenberg GF, Abt MC et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011; 12:1045-54.
53. Allakhverdi Z, Comeau MR, Smith DE et al. CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation. J Allergy Clin Immunol 2009; 123:472-8, e1.
54. Mjosberg JM, Trifari S, Crellin NK et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011; 12:1055-62.
55. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity 2010; 32:593-604.
56. Loke Pn, MacDonald AS, Allen JE. Antigen-presenting cells recruited by Brugia malayi induce Th2 differentiation of naïve CD4 + T cells. Eur J Immunol 2000; 30:1127-35.
57. Melgert BN, ten Hacken NH, Rutgers B, Timens W, Postma DS, Hylkema MN. More alternative activation of macrophages in lungs of asthmatic patients. J Allergy Clin Immunol 2011; 127:831-3.
58. Ford AQ, Dasgupta P, Mikhailenko I, Smith EM, Noben-Trauth N, Keegan AD. Adoptive transfer of IL-4Ralpha macrophages is sufficient to enhance eosinophilic inflammation in a mouse model of allergic lung inflammation. BMC Immunol 2012; 13:6.
59. Kim EY, Battaile JT, Patel AC et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med 2008; 14:633-40.
60. Shirey KA, Pletneva LM, Puche AC et al. Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R[alpha]-, TLR4-, and IFN-[beta]-dependent. Mucosal Immunol 2010; 3:291-300.
61. Pribul PK, Harker J, Wang B et al. Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development. J Virol 2008; 82:4441-8.
62. Grayson MH, Cheung D, Rohlfing MM et al. Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia. J Exp Med 2007; 204:2759-69.
63. Cheung DS, Ehlenbach SJ, Kitchens RT et al. Cutting edge: CD49d+ neutrophils induce FcepsilonRI expression on lung dendritic cells in a mouse model of postviral asthma. J Immunol 2010; 185:4983-7.
64. van Rijt LS, Vos N, Willart M et al. Persistent activation of dendritic cells after resolution of allergic airway inflammation breaks tolerance to inhaled allergens in mice. Am J Respir Crit Care Med 2011; 184:303-11.
65. Fattouh R, Pouladi MA, Alvarez D et al. House dust mite facilitates ovalbumin-specific allergic sensitization and airway inflammation. Am J Respir Crit Care Med 2005; 172:314-21.
66. Cai Y, Kumar RK, Zhou J, Foster PS, Webb DC. Ym1/2 promotes Th2 cytokine expression by inhibiting 12/15(S)-Lipoxygenase: identification of a novel pathway for regulating allergic inflammation. J Immunol 2009; 182:5393-9.
67. Beyer M, Bartz H, Hörner K, Doths S, Koerner-Rettberg C, Schwarze J. Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection. J Allergy Clin Immunol 2004; 113:127-33.
68. Dahl ME, Dabbagh K, Liggitt D, Kim S, Lewis DB. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol 2004; 5:337-43.
69. Stein RT, Martinez FD. Respiratory syncytial virus and asthma: still no final answer. Thorax 2010; 65:1033-4.
70. Kloepfer KM, Olenec JP, Lee WM et al. Increased H1N1 infection rate in children with asthma. Am J Respir Crit Care Med 2012; 4:277-83.
71. Corne JM, Marshall C, Smith S et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002; 359:831-4.
72. Drysdale SB, Wilson T, Alcazar M et al. Lung function prior to viral lower respiratory tract infections in prematurely born infants. Thorax 2010; 66:468-73.
73. Saglani S, Payne DN, Zhu J et al. Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med 2007; 176:858-64.
74. Pohunek P, Warner JO, Turzíková J, Kudrmann J, Roche WR. Markers of eosinophilic inflammation and tissue re-modelling in children before clinically diagnosed bronchial asthma. Pediatr Allergy Immunol 2005; 16:43-51.
75. Malmstrom K, Pelkonen AS, Malmberg LP et al. Lung function, airway remodelling and inflammation in symptomatic infants: outcome at 3 years. Thorax 2011; 66:157-62.
76. Tourdot S, Mathie S, Hussell T et al. Respiratory syncytial virus infection provokes airway remodelling in allergen-exposed mice in absence of prior allergen sensitization. Clin Exp Allergy 2008; 38:1016-24.
77. Papadopoulos NG, Stanciu LA, Papi A, Holgate ST, Johnston SL. A defective type 1 response to rhinovirus in atopic asthma. Thorax 2002; 57:328-32.
78. Hackett T-L, Singhera GK, Shaheen F et al. Intrinsic phenotypic differences of asthmatic epithelium and its inflammatory responses to Respiratory Syncytial Virus and air pollution. Am J Respir Cell Mol Biol 2011; 45:1090-100.
79. Wark PAB, Johnston SL, Bucchieri F et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005; 201:937-47.
80. Contoli M, Message SD, Laza-Stanca V et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006; 12:1023-6.
81. Bufe A, Gehlhar K, Grage-Griebenow E, Ernst M. Atopic phenotype in children is associated with decreased virus-induced interferon-alpha release. Int Arch Allergy Immunol 2002; 127:82-8.
82. Cakebread JA, Xu Y, Grainge C et al. Exogenous IFN-beta has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus. J Allergy Clin Immunol 2011; 127:1148-54, e9.
83. Moriwaki A, Matsumoto K, Matsunaga Y et al. IL-13 suppresses double-stranded RNA-induced IFN-lambda production in lung cells. Biochem Biophys Res Commun 2011; 404:922-7.
84. Bochkov YA, Hanson KM, Keles S, Brockman-Schneider RA, Jarjour NN, Gern JE. Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol 2009; 3:69-80.
85. Tversky JR, Le TV, Bieneman AP, Chichester KL, Hamilton RG, Schroeder JT. Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-alpha via Toll-like receptor 9. Clin Exp Allergy 2008; 38:781-8.
86. Gill MA, Bajwa G, George TA et al. Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells. J Immunol 2010; 184:5999-6006.
87. Heymann PW, Carper HT, Murphy DD et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol 2004; 114:239-47.
88. Fernandes RM, Bialy LM, Vandermeer B et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 2010; CD004878.
89. Chen CH, Lin YT, Yang YH et al. Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitization. Pediatr Allergy Immunol 2008; 19:166-72.
90. Simoes EA, Carbonell-Estrany X, Rieger CH, Mitchell I, Fredrick L, Groothuis JR. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J Allergy Clin Immunol 2010; 126:256-62.
91. Scottish Intercollegiate Guidelines Network. 2013. British guideline on the management of asthma. Available at: http://www.sign.ac.uk/guidelines/fulltext/101. (Accessed 17th May 2013).
92. Davies JM, Carroll ML, Li H et al. Budesonide and formoterol reduce early innate anti-viral immune responses in vitro. PLoS ONE 2011; 6:e27898.
93. Prazma CM, Kral KM, Gul N, Yancey SW, Stempel DA. Controller medications and their effects on asthma exacerbations temporally associated with upper respiratory infections. Respir Med 2010; 104:780-7.
94. Edwards MR, Johnson MW, Johnston SL. Combination therapy. Am J Respir Cell Mol Biol 2006; 34:616-24.
95. Robertson CF, Price D, Henry R et al. Short-Course Montelukast for intermittent asthma in children. Am J Respir Crit Care Med 2007; 175:323-9.
96. Kloepfer KM, DeMore JP, Vrtis RF et al. Effects of montelukast on patients with asthma after experimental inoculation with human rhinovirus 16. Ann Allergy Asthma Immunol 2011; 106:252-7.
97. Busse WW, Morgan WJ, Gergen PJ et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med 2011; 364:1005-15.
98. Rabatic S, Gagro A, Lokar-Kolbas R et al. Increase in CD23+ B cells in infants with bronchiolitis is accompanied by appearance of IgE and IgG4 antibodies specific for respiratory syncytial virus. J Infect Dis 1997; 175:32-7.
99. Welliver RC, Wong DT, Sun M, Middleton E Jr, Vaughan RS, Ogra PL. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 1981; 305:841-6.
100. Dakhama A, Lee YM, Ohnishi H et al. Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice. J Allergy Clin Immunol 2009; 123:138-45, e5.
101. Edwards MR, Kebadze T, Johnson MW, Johnston SL. New treatment regimes for virus-induced exacerbations of asthma. Pulm Pharmacol Ther 2006; 19:320-34.
102. Gielen V, Johnston SL, Edwards MR. Azithromycin induces anti-viral responses in bronchial epithelial cells. Eur Respir J 2010; 36:646-54.